Cargando…
Risk model of hepatocellular carcinoma based on cuproptosis-related genes
Background: Owing to the heterogeneity displayed by hepatocellular carcinoma (HCC) and the complexity of tumor microenvironment (TME), it is noted that the long-term effectiveness of the cancer therapy poses a severe clinical challenge. Hence, it is essential to categorize and alter the treatment in...
Autores principales: | Liu, Zhiqiang, Qi, Yong, Wang, Haibo, Zhang, Qikun, Wu, Zhengsheng, Wu, Wenyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521278/ https://www.ncbi.nlm.nih.gov/pubmed/36186455 http://dx.doi.org/10.3389/fgene.2022.1000652 |
Ejemplares similares
-
Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma
por: Fu, Jie, et al.
Publicado: (2022) -
Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022) -
CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway
por: Qi, Yong, et al.
Publicado: (2022) -
Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
por: Zhu, Hongfei, et al.
Publicado: (2022) -
An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)